Sectors

IMDX
Insight Molecular Diagnostics Inc.
3.92
2 x 2.95
2 x 5.03
bid
ask
-
0.21
5.08%
2 @ 04:10 PM
3.92 +0.00 (0.00%)
Ytd-47.73%
1y54.94%
3.88
day range
4.12
2.40
52 week range
8.51
Open4.10Prev Close4.13Low3.88High4.12Mkt Cap128.28M
Vol102.40KAvg Vol218.57KEPS-1.52P/EN/AForward P/EN/A
Beta1.79Short RatioN/AInst. OwnN/ADividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-0950-d Avg4.82200-d Avg5.331yr Est0.00
Income Statement
Total Revenue239.00K
Revenues (USD)239.00K
Cost of Revenue82.00K
Gross Profit157.00K
Operating Expenses11.56M
Research and Development Expense4.49M
Selling, General and Administrative Expense4.79M
Operating Income-11.40M
Interest Expense20.00K
Net Income-11.26M
Net Income Common Stock-11.26M
Net Income Common Stock (USD)-11.26M
Consolidated Income-11.26M
Earnings per Basic Share-0.31
Earnings per Basic Share (USD)-0.31
Earnings per Diluted Share-0.31
Earning Before Interest & Taxes (EBIT)-11.24M
Earning Before Interest & Taxes (USD)-11.24M
Weighted Average Shares36.75M
Weighted Average Shares Diluted36.75M
Balance Sheet
Cash and Equivalents18.49M
Cash and Equivalents (USD)18.49M
Trade and Non-Trade Receivables192.00K
Current Assets20.54M
Property, Plant & Equipment Net8.10M
Total Assets29.44M
Debt Current1.71M
Total Debt2.63M
Current Liabilities10.29M
Debt Non-Current915.00K
Total Liabilities50.74M
Accumulated Retained Earnings (Deficit)-416.31M
Accumulated Other Comprehensive Income67.00K
Shareholders Equity-21.30M
Shareholders Equity (USD)-21.30M
Assets Non-Current8.90M
Total Debt (USD)2.63M
Inventory207.00K
Liabilities Non-Current40.46M
Trade and Non-Trade Payables3.85M
Cash Flow
Depreciation, Amortization & Accretion665.00K
Net Cash Flow from Financing-564.00K
Net Cash Flow / Change in Cash & Cash Equivalents-10.63M
Capital Expenditure-779.00K
Issuance (Purchase) of Equity Shares10.00K
Issuance (Repayment) of Debt Securities -152.00K
Net Cash Flow from Investing-779.00K
Net Cash Flow from Operations-9.27M
Effect of Exchange Rate Changes on Cash -16.00K
Share Based Compensation669.00K